Both in Pharmaceuticals
ABBVIE vs Pfizer
Over the past year ABBV returned +35.2% and PFE returned +23.8%; their daily moves had a correlation of 0.37.
ABBV +35.2% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | ABBV | PFE |
|---|---|---|
| Price | $294.89 | $30.52 |
| Market cap | $521.11B | $173.95B |
| Today | +1.41% | +1.90% |
| 1 month | +13.4% | +8.5% |
| 6 months | +42.7% | +15.9% |
| Year to date | +29.1% | +22.6% |
| 1 year | +31.0% | +25.6% |
| Revenue growth (YoY) | +10.2% | +2.6% |
| Gross margin | 74.7% | 72.8% |
| Net margin | 21.3% | −1.6% |
| P/E (TTM) | 82.8× | 40.2× |
| Price / sales | 8.1× | 2.7× |
| Net cash | -$64.25B | -$51.49B |
| Dividend yield | 2.35% | 5.64% |
| Volatility (60d) | 19.6% | 19.8% |
| Short % of float | 0.9% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).